-
474NewsGPE Launches Virtual Reality Film on Climate Change And Education
WASHINGTON D.C., MAPUTO – Media OutReach – 23 October 2023 – The Global Partnership for Education (GPE) launched today Education in the...
-
456Wire StoriesGenexine and KGbio received the first market approval for novel long-acting Erythropoietin, Efepoetin alfa, from The Indonesian Food and Drug Authority (BPOM)
First market approval for Genexine discovered and developed therapeutic drug, Efesa (Efepoetin alfa), a long-acting erythropoietin (EPO) for the treatment of Chronic...
-
423Wire StoriesNational Football League Teams Up with SES for Game Content Distribution
In a renewed partnership, SES’s hybrid distribution network to enable the NFL to reach over 35 partners in Europe, Asia and the...
-
351Wire StoriesCelltrion, Inc. & Celltrion Healthcare Co., Ltd. Announce Shareholders Approval of Merger
On October 23rd, at the EGM of shareholders, the merger agreement between Celltrion, Inc. & Celltrion Healthcare Co., Ltd. was approved Celltrion...
-
392Wire StoriesNidec Announces Financial Results for Fiscal Second Quarter and Six Months Ended September 30, 2023
KYOTO, Japan–(BUSINESS WIRE)–Nidec Corporation (TOKYO:6594) (OTC US:NJDCY) today announced its consolidated financial results under the International Financial Reporting Standards (“IFRS”) for the...
-
402Wire StoriesNidec Announces Differences between Projected and Actual Financial Results for First-Half FY2023
KYOTO, Japan–(BUSINESS WIRE)–Nidec Corporation (TOKYO: 6594; OTC US: NJDCY) (the “Company”) today announced differences between its financial forecast for the six months...
-
493NewsRamagrama Stupa the Sole Undisturbed Original Stupa Containing Relics of Lord Buddha to be Preserved and Developed
LUMBINI, NEPAL – Media OutReach – 23 October 2023 – The Promised Land is pleased to announce the signing of a Memorandum...
-
375NewsFHA-HoReCa announces new initiatives and partnerships for 2024 edition, covering Technology Solutions and Talent recognition
Anticipate the debut of first-ever FSTEC Asia – catering to the surging demand for technology solutions among APAC restaurant companies – from...
-
568Wire StoriesENHERTU® Approved in the EU as the First HER2 Directed Therapy for Patients with HER2 Mutant Advanced Non-Small Cell Lung Cancer
Approval based on DESTINY-Lung02 trial results where Daiichi Sankyo and AstraZeneca’s ENHERTU demonstrated a confirmed objective response rate of 49.0% and median...
-
422Wire StoriesBias in AI Computer Vision Systems Dramatically Reduced with Synthetic Data ‘Digital Humans’
Mindtech’s Digital DNA technology creates a diverse range of Digital Humans that allow for statistically fair representation of the eight billion real...
